Ocumension Therapeutics Revenue

In the year 2025, Ocumension Therapeutics had annual revenue of 804.35M CNY with 92.75% growth. Ocumension Therapeutics had revenue of 510.32M in the half year ending December 31, 2025, with 257.69% growth.

Revenue

804.35M CNY

Revenue Growth

+92.75%

P/S Ratio

6.83

Revenue / Employee

1.46M CNY

Employees

552

Market Cap

6.12B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	804.35M	387.05M	92.75%
Dec 31, 2024	417.31M	170.94M	69.38%
Dec 31, 2023	246.37M	87.41M	54.99%
Dec 31, 2022	158.96M	102.81M	183.11%
Dec 31, 2021	56.15M	43.05M	328.73%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Laekna	118.76M
Jacobio Pharmaceuticals Group	59.56M
CK Life Sciences Int'l., (Holdings)	5.41B
Guangzhou Innogen Pharmaceutical Group	146.34M
Shandong Boan Biotechnology	873.36M
Shanghai Haohai Biological Technology	2.73B
Abbisko Cayman	681.17M
Qyuns Therapeutics	897.99M

Revenue Rankings